Manja Idorn
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Role for NF-κB in herpes encephalitis pathology in mice genocopying an inborn error of IRF3-IFN immunity.
Journal: The Journal of experimental medicine
Published: January 10, 2025
The heat shock protein 90 inhibitor RGRN-305 attenuates SARS-CoV-2 spike protein-induced inflammation in vitro but lacks effectiveness as COVID-19 treatment in mice.
Journal: PloS one
Published: April 07, 2024
STING signals to NF-κB from late endolysosomal compartments using IRF3 as an adaptor.
Journal: Nature immunology
Published: November 07, 2023
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages.
Journal: Communications biology
Published: October 31, 2023
Characterization of SARS-CoV-2 humoral immune response in a subject with unique sampling: A case report.
Journal: Immunity, inflammation and disease
Published: April 02, 2023
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2.
Journal: The Lancet. Microbe
Published: September 05, 2022
TMEFF1 is a neuron-specific restriction factor for herpes simplex virus.
Journal: Nature
Published: August 09, 2022
Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1.
Journal: EMBO reports
Published: July 22, 2022
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 18, 2022
A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques.
Journal: Frontiers in immunology
Published: January 18, 2022
Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern.
Journal: ACS infectious diseases
Published: October 18, 2021
A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 11, 2021
Last Updated: 09/26/2026